Black Friday Sale: 20% off everything. Ends Tuesday 1 December, 11:59 pm AEDT.
For laboratory and research use only. Not for human consumption.  Sold exclusively to qualified researchers and licensed laboratories.

CATALOGUE  /  BPC-157

BPC-157 10MG

BPC-157, lyophilised powder in a sealed vial

BPC-157

Research peptide · Lyophilised powder in a sealed vial · for laboratory and research use only

BPC-157 10mg Quantity per vial: 10mg
$99.99$79.99
Secure card payments
Not a drug, food or cosmetic. For laboratory and research use only. Not for human consumption. This product has not been evaluated or approved by the US Food and Drug Administration (FDA) or the Australian Therapeutic Goods Administration (TGA), and it is not intended to diagnose, treat, cure or prevent any disease. Sold exclusively to qualified researchers and licensed laboratories.

Reagent specifications

CAS number137525-51-0
Molecular weight1419.5 g/mol (free peptide; PubChem reference value)
StorageSealed, dry and dark at −20 °C or colder; −50 to −80 °C for long-term storage
Certificate of analysisAvailable on request · Request a COA

CAS number and molecular weight are reference values for the compound identity, from PubChem. Salt forms, such as a trifluoroacetate, have a different formula and mass.

Compound identity

Compound classSynthetic linear peptide (pentadecapeptide, 15 residues)
Sequence (one-letter)GEPPPGKPADDAGLV
Sequence (three-letter)Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular formulaC62H98N16O22 (free peptide, PubChem)
PubChem CID9941957
Other namesPL 14736, PLD-116, PL-10, bepecin
Supplied asLyophilised powder, sealed vial
Quantity per vial10 mg
Intended useLaboratory and research use only

About BPC-157

BPC-157 is a synthetic pentadecapeptide, a linear chain of 15 amino acids with the sequence GEPPPGKPADDAGLV.1 It was first described in 1993 by researchers at the University of Zagreb as a partial sequence of a larger protein they reported in gastric juice. Research material is made by solid-phase peptide synthesis, not extracted.

Titan Peptides supplies BPC-157 as a lyophilised powder in a sealed 10 mg vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.

Status in Australia

In Australia, BPC-157 is listed in Schedule 4 (Prescription Only Medicine) of the Poisons Standard June 2026 (F2026L00633) and in Appendix D, clause 5, which lists poisons that must not be possessed without authority.2 The TGA's safety advisory of 13 April 2026 names BPC-157 as an example of an unapproved peptide product and states that a "research use only" disclaimer does not make its supply lawful.3

BPC-157 is not an approved therapeutic good in Australia; the vial sold here is a research chemical. Our guide to research peptides and Australian law explains how scheduling applies.

Laboratory handling & storage

Keep the sealed vial dry, dark and frozen at −20 °C or colder, and colder still (−50 to −80 °C) for long-term storage. Let it reach room temperature in a desiccator before opening, so moisture does not condense on the hygroscopic powder. The sequence has none of the cysteine, methionine or tryptophan residues most prone to oxidation, nor the asparagine or glutamine residues prone to deamidation, but solutions are still short-lived: split a reconstituted stock into single-use aliquots, freeze them, and discard a thawed aliquot rather than refreezing it. See how to store peptides and reconstituting peptides with bacteriostatic or sterile water for the reasoning behind each step.

BPC-157 quick answers

What form is BPC-157 supplied in?

BPC-157 is supplied as a lyophilised (freeze-dried) powder in a sealed vial containing 10 mg, for laboratory and research use only. Peptides are often supplied as salts, and PubChem also records a trifluoroacetate form of BPC-157, so documentation for a salt form can list a different formula and mass from the free-peptide values of C62H98N16O22 and 1419.5 g/mol.

What is BPC-157's CAS number?

The CAS number for BPC-157 is 137525-51-0, and its PubChem compound ID is 9941957. The same peptide appears in the literature under the codes PL 14736, PLD-116 and PL-10, and as bepecin, so searching under every name captures the full chemical literature.

What is BPC-157's legal status in Australia?

BPC-157 is a Schedule 4 substance in the June 2026 Poisons Standard and is also listed in Appendix D, clause 5, which covers poisons that must not be possessed without authority. The TGA names it as an unapproved peptide product and says a research-use-only label does not make supply lawful. States and territories implement scheduling through their own legislation.

How is BPC-157 different from TB-500?

They are unrelated molecules. BPC-157 is a linear 15-residue peptide (GEPPPGKPADDAGLV, 1419.5 g/mol); TB-500 is a synthetic, N-acetylated seven-residue fragment of thymosin beta-4 (Ac-LKKTETQ, 889.0 g/mol). Their molar masses differ by about 530 g/mol, so mass spectrometry distinguishes them easily.

From the research library

Compound Profiles

BPC-157: Compound Profile, Structure and Regulation

A chemical profile of BPC-157: the 15-residue sequence and its identifiers, salt forms, how identity is checked in the laboratory, storage, and its place in the Australian Poisons Standard.

21 September 2026 · 3 min read
Science Explained

How to Read a Peptide Certificate of Analysis (COA)

A section-by-section guide to reading a peptide certificate of analysis: identity, HPLC purity, net peptide content, counter-ions, water, endotoxin, and the red flags that mean a COA does not check out.

21 September 2026 · 8 min read

References

  1. PubChem. BPC-157, CID 9941957. National Center for Biotechnology Information. Source
  2. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 (Standard for the Uniform Scheduling of Medicines and Poisons No. 48), F2026L00633. Commenced 1 June 2026. Federal Register of Legislation. Source
  3. Therapeutic Goods Administration. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products (safety advisory). Published 13 April 2026. Source
Research use only. Not a drug, food or cosmetic. BPC-157 is supplied strictly for laboratory and in-vitro research and is not for human consumption. It is not an approved therapeutic good in Australia, has not been evaluated or approved by the FDA or the TGA, and is not intended to diagnose, treat, cure or prevent any disease. Titan Peptides sells exclusively to qualified researchers and licensed laboratories.